🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yaron Ilan

Hadassah Medical Center

ORCID: 0000-0003-0802-1220
MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 5 papers. Top paper: “Immune digital twins for complex human pathologies: applications, limitations, and challenges”.

Immune digital twins for complex human pathologies: applications, limitations, and challenges

npj Systems Biology and Applications(2024)10.1038/s41540-024-00450-5
N/A
0.652DataRank · unranked
76 citations

Reinhard Laubenbacher, Gary An, Yaron Ilan, Jasmin Fisher, Åsmund Flobak +42 more

Why targeting the microbiome is not so successful: can randomness overcome the adaptation that occurs following gut manipulation?

Clinical and Experimental Gastroenterology(2019)10.2147/ceg.s203823
N/A
0.650DataRank · unranked
75 citations

Yaron Ilan

The Relationship Between Biological Noise and Its Application: Understanding System Failures and Suggesting a Method to Enhance Functionality Based on the Constrained Disorder Principle

Biology(2025)10.3390/biology14040349
N/A
0.385DataRank · unranked
12 citations

Yaron Ilan

Oral Insulin Alleviates Liver Fibrosis and Reduces Liver Steatosis in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes: Results of Phase II Randomized, Placebo-controlled Feasibility Clinical Trial

Gastro Hep Advances(2023)10.1016/j.gastha.2023.11.016
N/A
0.208DataRank · unranked
3 citations

Joel Neutel, Yotam Kolben, Ram Gelman, Orly Sneh Arbib, O López +5 more

A Feasibility Open-Labeled Clinical Trial Using a Second-Generation Artificial-Intelligence-Based Therapeutic Regimen in Patients with Gaucher Disease Treated with Enzyme Replacement Therapy

Journal of Clinical Medicine(2024)10.3390/jcm13113325
N/A
0DataRank · unranked
20 citations

Tama Dinur, Shoshana Revel‐Vilk, Samuel Agus, Marc Berg, Ari Zimran +2 more